The document discusses placental abruption, which is the separation of the placenta from the uterus prior to delivery. It defines placental abruption and notes that 15% occur during labor and 30% are only identified after delivery. Placental abruption is classified into three grades based on symptoms, from slight vaginal bleeding to severe bleeding. Treatment involves managing hemorrhage, shock, and coagulopathy, as well as assessing the need for early delivery of the fetus depending on the condition of the mother and baby.
Introduction
Lead to tubal rupture;
massive intra-abdominal hemorrhage —> death;
Tubal damage —> poor reproductive outcome;
It is the leading pregnancy-related cause of death in the first trimester.
With reliable serum pregnancy tests and vaginal ultrasound, early detection and treatment of an ectopic pregnancy is possible.
A miscarriage, or spontaneous abortion, is an event that results in the loss of a fetus before 20 weeks of pregnancy. It typically happens during the first trimester, or first three months, of the pregnancy. Miscarriages can happen for a variety of medical reasons, many of which aren't within a person's control.
Presented by
Ahmed Mukhtar
M.B.B.Ch., M.Sc Obstetrics and GynecologyAssistante lecturer of Obstetrics and Gynecology
Faculty of Medicine, Zagazig University
Anaesthetic management of ruptured ectopic pregnancy by Arowojolu BoluwajiArowojolu Samuel
anaesthetic management of a patient with ruptured ectopic pregnancy. helping anaesthetist to know what to do in emergency anaesthesia. this is an emergency case. salpingectomy. arowojolu boluwaji
Introduction
Lead to tubal rupture;
massive intra-abdominal hemorrhage —> death;
Tubal damage —> poor reproductive outcome;
It is the leading pregnancy-related cause of death in the first trimester.
With reliable serum pregnancy tests and vaginal ultrasound, early detection and treatment of an ectopic pregnancy is possible.
A miscarriage, or spontaneous abortion, is an event that results in the loss of a fetus before 20 weeks of pregnancy. It typically happens during the first trimester, or first three months, of the pregnancy. Miscarriages can happen for a variety of medical reasons, many of which aren't within a person's control.
Presented by
Ahmed Mukhtar
M.B.B.Ch., M.Sc Obstetrics and GynecologyAssistante lecturer of Obstetrics and Gynecology
Faculty of Medicine, Zagazig University
Anaesthetic management of ruptured ectopic pregnancy by Arowojolu BoluwajiArowojolu Samuel
anaesthetic management of a patient with ruptured ectopic pregnancy. helping anaesthetist to know what to do in emergency anaesthesia. this is an emergency case. salpingectomy. arowojolu boluwaji
Ectopic Pregnancy - Obstetrical & Gynaecological NursingJaice Mary Joy
In ectopic pregnancy, implantation occupies at a site other than the endometrium. Ectopic pregnancies are responsible for approximately 10 percent of all maternal mortality. The prognosis for future reproduction is poor. Only one half of women having an ectopic pregnancy are eventually delivered of a liveborn infant. Various factors contribute to ectopic pregnancies, the most common being infection. Unlike intrauterine spontaneous abortions, genetic factors are not paramount in the etiology of ectopic pregnancy.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
2. GENERAL CONSIDERATION
Definition
The separation of the placenta from
its site of implantation after 20 weeks
of gestation or during the course of
delivery.
15% occur during labor, and 30% are
identified only by inspection of the
placenta after delivery.
Frequency
1% per pregnant s .
Incidence of fetal death
200‰-350‰
3. ETIOLOGY AND CLASSIFICATIONS
At the initial point of placental separation, non
clotted blood courses from the site of injury.
The enlarging collection of blood may cause
further separation of the placenta. Bleeding
can be either concealed or revealed
(apparent). A concealed hemorrhage occurs
in 20% of cases and describes an abruption
in which the bleeding is confined within the
uterine cavity. The most common abruption
is associated with a revealed or external
hemorrhage, where the blood dissects
downward toward the cervix . Placental
abruption may be broadly classified into
three grades that correlate with clinical and
laboratory findings .
4. Classifications of Placenta Abruption
Grade 1: Slight vaginal bleeding and some uterine
irritability are usually present.
Grade 2: External uterine bleeding is absent to
moderate. The uterus is irritable and tetanic or very
frequent contractions may be present.
Grade 3: Bleeding is moderate to severe but may be
concealed. The uterus is tetanic and painful. Maternal
hypotension is frequently present and fetal death has
occurred.
5. ETIOLOGY
Uncertain (primary cause)
Risk factors
1. Increased age and parity
2. Vascular diseases: preeclampsia,
chronic hypertension, renal disease.
3. Mechanical factors: trauma,
intercourse, polyhydramnios,
4. Supine hypotensive syndrome
5. Smoking, cocaine use, uterine
myoma(masses)
6. Are pregnant with twins or triplets
7. Have had a previous placental
abruption
6. PATHOLOGY
Main change
hemorrhage into the decidua basalis
→ decidua splits → decidural
hematoma → separation, compression,
destruction of the placenta adjacent to
it
Types
revealed abruption, concealed
abruption, mixed type
12. MANIFESTATION
Vaginal bleeding companied with abdominal
pain
Mild type
abruption ≤ 1/3, apparent vaginal
bleeding
Severe type
abruption > 1/3, large retroplacental
hematoma, vaginal bleeding companied
by persistent abdominal pain, tenderness
on the uterus, change of fetal heart rate.
shock and renal failure.
13. ADJUNCTIVE EXAMINATION
Ultrasonography
1. Position of placenta, severity of
abruption, survival of fetus
2. Signs: retro placental hematoma
3. Negative findings do not exclude
placental abruption
Laboratory examination
1. consumptive coagulopathy: DIC
2. Function of liver and kidney.
14.
15. DIAGNOSIS
sign and symptom
1. Vaginal bleeding
2. Uterine tenderness or back pain
3. Fetal distress
4. High frequency contractions
5. Hyper tonus ~
the elastic tension of living muscles
6. Idiopathic preterm labor
7. Dead fetus
Vaginal bleeding in the third trimester of
pregnancy is the hallmark of placental
abruption or placenta previa
18. DIC
- An acquired
syndrome
characterized by
the intravascular
activation of
coagulation with
loss of localization
arising from
different causes. It
can originate from
and cause damage
to the
microvasculature,
which if sufficiently
severe, can produce
organ dysfunction.
19. TREATMENT
1- Treatment will vary depending upon
gestational age and the status of
mother and fetus
2- Treatment of hypovolemic shock:
intensive transfusion with blood
3- Assessment of fetus
4- Termination of pregnancy: CS or
Vaginal delivery
20. TREATMENT
Treatment of consumptive coagulopathy
1. Supplement of coagulation factors:
fresh blood, frozen blood plasma,
fibrinogen, blood platelet.
2. Heparin: high coagulation
3. Anti-fibrinolysis
Prevention of renal failure
21. MANAGEMENT:
The potential for rapid deterioration
(hemorrhage, disseminated intravascular
coagulation [DIC], fetal hypoxia)
necessitates delivery in some cases of
placental abruption. However, most
abruptions are small and non-
catastrophic, and therefore do not
necessitate immediate delivery. Certain
actions, including hospitalization,
laboratory studies, continuous
monitoring, and ongoing patient support
should be initiated when placental
abruption is suspected
22. CARE FOR THE PATIENT WITH
ABRUPTION PLACENTAE
* Hospitalization
• Intravenous placement with a large-bore catheter (16-gauge)
• Lab work: Includes CBC, coagulation studies (fibrinogen, PT,
PTT, platelet count, fibrin degradation products), type and screen
for 4 units of blood Betamethasone may be given to the woman
to promote fetal lung maturity when delivery is not imminent.
• Rh(D)-negative patients should receive RhoGAM to prevent
isoimmunization.
• Continuous evaluation of intake and output
• Continuous electronic fetal monitoring
• Delivery (cesarean or vaginal birth) may be initiated depending
on the status of the mother and the fetus.
• Nursing care is centered on continuous maternal–fetal
assessment, with on-going information and emotional support for
the patient and her family.
24. REVIEW:
Q1- When does the separation of the placenta
happen?
Q2- what is the hallmark of placenta
abruption?
Q3- what are the types of placenta abruption?
Q4- what is the 3 types of placenta abruption?
Q5- how to care for a patient of placenta
abruption?